These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36444905)

  • 41. Test-retest reliability of the Friedreich's ataxia rating scale.
    Rummey C; Zesiewicz TA; Perez-Lloret S; Farmer JM; Pandolfo M; Lynch DR
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1708-1712. PubMed ID: 32779859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia. Results of a double-blind drug-placebo cooperative study.
    Trouillas P; Serratrice G; Laplane D; Rascol A; Augustin P; Barroche G; Clanet M; Degos CF; Desnuelle C; Dumas R
    Arch Neurol; 1995 May; 52(5):456-60. PubMed ID: 7733839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction to Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).
    Lynch D
    Ann Neurol; 2023 Dec; 94(6):1190. PubMed ID: 37795909
    [No Abstract]   [Full Text] [Related]  

  • 44. Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database.
    Metz G; Coppard N; Cooper JM; Delatycki MB; Dürr A; Di Prospero NA; Giunti P; Lynch DR; Schulz JB; Rummey C; Meier T
    Brain; 2013 Jan; 136(Pt 1):259-68. PubMed ID: 23365101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Brassington R; Pandolfo M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007791. PubMed ID: 27572719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Friedreich's ataxia and scoliosis: the experience at two institutions.
    Milbrandt TA; Kunes JR; Karol LA
    J Pediatr Orthop; 2008 Mar; 28(2):234-8. PubMed ID: 18388721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
    Lynch DR; Perlman SL; Meier T
    Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
    Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M
    Acta Neurol Scand; 2014 Jan; 129(1):32-40. PubMed ID: 23668357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal gait and balance decline in Friedreich's Ataxia: A pilot study.
    Zesiewicz TA; Stephenson JB; Kim SH; Sullivan KL; Jahan I; Huang Y; Salemi JL; Wecker L; Shaw JD; Gooch CL
    Gait Posture; 2017 Jun; 55():25-30. PubMed ID: 28411441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.
    Boesch S; Sturm B; Hering S; Goldenberg H; Poewe W; Scheiber-Mojdehkar B
    Ann Neurol; 2007 Nov; 62(5):521-4. PubMed ID: 17702040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
    Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
    Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional and Gait Assessment in Children and Adolescents Affected by Friedreich's Ataxia: A One-Year Longitudinal Study.
    Vasco G; Gazzellini S; Petrarca M; Lispi ML; Pisano A; Zazza M; Della Bella G; Castelli E; Bertini E
    PLoS One; 2016; 11(9):e0162463. PubMed ID: 27598307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental drugs for Friedrich's ataxia: progress and setbacks in clinical trials.
    Boesch S; Indelicato E
    Expert Opin Investig Drugs; 2023; 32(11):967-969. PubMed ID: 37886821
    [No Abstract]   [Full Text] [Related]  

  • 55. Morphologic and functional characteristics of the heart in Friedreich's ataxia.
    Unverferth DV; Schmidt WR; Baker PB; Wooley CF
    Am J Med; 1987 Jan; 82(1):5-10. PubMed ID: 3799693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich's Ataxia.
    Vavla M; Arrigoni F; Toschi N; Peruzzo D; D'Angelo MG; Gandossini S; Russo A; Diella E; Tirelli S; Salati R; Rufini A; Condo I; Testi R; Martinuzzi A
    Front Neurosci; 2020; 14():872. PubMed ID: 33162876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging therapies in Friedreich's Ataxia.
    Zesiewicz TA; Hancock J; Ghanekar SD; Kuo SH; Dohse CA; Vega J
    Expert Rev Neurother; 2020 Dec; 20(12):1215-1228. PubMed ID: 32909841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NfL and pNfH are increased in Friedreich's ataxia.
    Hayer SN; Liepelt I; Barro C; Wilke C; Kuhle J; Martus P; Schöls L;
    J Neurol; 2020 May; 267(5):1420-1430. PubMed ID: 32002649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia.
    Saccà F; Puorro G; Marsili A; Antenora A; Pane C; Casali C; Marcotulli C; Defazio G; Liuzzi D; Tatillo C; Cambriglia DM; Schiano di Cola G; Giuliani L; Guardasole V; Salzano A; Ruvolo A; De Rosa A; Cittadini A; De Michele G; Filla A
    Mov Disord; 2016 May; 31(5):734-41. PubMed ID: 26879839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.